← Back to Patent Explorer
US4283489A Expired / Lapsed US ⏱️ 0.0 years remaining

Purification of nucleotide sequences suitable for expression in bacteria

Assignee: University of California, San Diego
•
Filing: 1979-11-23
•
Granted: 1981-08-11
•
Expires: 1999-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method has been discovered for purifying a specific desired DNA sequence, starting from RNA heterogeneous in length and sequence. The steps of the method include making complementary DNA transcripts of the RNA by means of an enzyme such as reverse transcriptase, subjecting the DNA transcripts to the action of one or more selected restriction endonuclease enzymes, and fractionating the fragments produced by endonuclease action according to their length. By this method it is possible to isolate homogeneous length DNA fragments complementary to RNA sequences present in the original preparation in as low a frequency as two percent. A method is also disclosed for further purifying the homogeneous length fragments and for determining their final purity. Using the disclosed methods, a DNA fragment approximately 550 nucleotides in length coding for a portion of the peptide hormone, human chorionic somatomammotropin, has been purified to greater than 99% purity.

Inventors

  • 👤 Howard M. Goodman
  • 👤 John Shine
  • 👤 Peter Horst

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 17:17
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1003; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/57518; C12N15/1096

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 127 words
A method for measuring the purity of a specific desired nucleotide sequence in a preparation of DNA fragments of essentially homogeneous length containing said nucleotide sequence, there being at least one restriction site within the specific desired nucleotide sequence, comprising the steps of: a. subjecting the DNA preparation to the action of a restriction endonuclease capable of catalyzing the hydrolysis of the specific desired nucleotide sequence at the restriction site within the sequence, in order to produce identifiable sub-fragments thereof, b. separating the restriction endonuclease treated DNA sub-fragments according to their length, and c. measuring the amount of the DNA preparation identifiable as sub-fragments of the specific desired nucleotide sequence, compared to the total amount of DNA, thereby measuring the purity of the specific desired nucleotide sequence.
Claim 2
Independent Claim 127 words
A method for measuring the purity of a specific desired nucleotide sequence in a preparation of DNA fragments of essentially homogeneous length containing said nucleotide sequence, there being at least one restriction site within the specific desired nucleotide sequence, comprising the steps of: a. subjecting the DNA preparation to the action of a restriction endonuclease capable of catalyzing the hydrolysis of the specific desired nucleotide sequence at the restriction site within the sequence, in order to produce identifiable sub-fragments thereof, b. separating the restriction endonuclease treated DNA sub-fragments according to their length, and c. measuring the amount of the DNA preparation identifiable as sub-fragments of the specific desired nucleotide sequence, compared to the total amount of DNA, thereby measuring the purity of the specific desired nucleotide sequence.
Claim 3
Dependent Claim 27 words
A method according to claim 1 wherein the DNA is labeled with a radioactive substance and the amount of the radioactive DNA is measured in step c.
Claim 4
Dependent Claim 17 words
A method according to claim 1 wherein the separation of step b, is accomplished by gel electrophoresis.
Claim 5
Dependent Claim 28 words
A method according to claim 3 wherein the DNA is labeled with a radioactive substance and the amount of radioactive DNA is measured in step c. by autoradiography.
Claim 6
Dependent Claim 14 words
A method according to claim 1 wherein the DNA consists essentially of double-stranded DNA.

References Cited (Backward Citations)

US4080261A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-08-10 1985-02-09 1985-08-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-08-10 1989-02-09 1989-08-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-08-10 1993-02-09 1993-08-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag